NCT06654648 Combined Exercise and Nutrition Intervention for Sarcopenia
| NCT ID | NCT06654648 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seoul Bumin Hospital |
| Condition | Sarcopenia |
| Study Type | INTERVENTIONAL |
| Enrollment | 118 participants |
| Start Date | 2022-03-29 |
| Primary Completion | 2024-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 118 participants in total. It began in 2022-03-29 with a primary completion date of 2024-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to demonstrate the effect of combined exercise-nutrition intervention in old adults with sarcopenia. This study will be conducted with prospectively randomized controlled trial comparing outcome of combined exercise-nutrition intervention with conventional medical care. Handgrip strength, gait speed, knee extensor muscle power, physical performance, muscle mass using DEXA, quality of life, activities of daily living, sarcopenia screening questionnaire, nutritional assessment will be evaluated on baseline, 12-weeks and 24-weeks after intervention
Eligibility Criteria
Inclusion Criteria: * patients older than 65 years and under 90 years * patients who meet the criteria for the Asian Working Group for Sarcopenia (AWGS) 2019 * patients who had metabolic syndrome Exclusion Criteria: * patients with less than estimated glomerular filtration rate (eGFR) 30 * patients with musculoskeletal or chronic lung disease incapable of exercise * patients with untreated or uncontrolled cardiovascular disease which may affect muscle mass or performing exercise * patients less than 5 years after treatment of malignant tumor * patients with liver cirrhosis, diabetes and other chronic disease * patients who cannot perform combined exercise nutrition intervention for other reasons
Contact & Investigator
Yongchan Ha, phD
PRINCIPAL INVESTIGATOR
Bumin Hospital(Seoul)
Frequently Asked Questions
Who can join the NCT06654648 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, up to 90 Years, studying Sarcopenia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06654648 currently recruiting?
Yes, NCT06654648 is actively recruiting participants. Contact the research team at hayongch@naver.com for enrollment information.
Where is the NCT06654648 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06654648 clinical trial?
NCT06654648 is sponsored by Seoul Bumin Hospital. The principal investigator is Yongchan Ha, phD at Bumin Hospital(Seoul). The trial plans to enroll 118 participants.